Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study on the Immune-response to SARS-CoV-2 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study

NCT04800146 is registered in ClinicalTrials.gov with Ilaria Colombo as lead sponsor.

NCT NCT04800146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04800146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study on the Immune-response to SARS-CoV-2 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study
Lead sponsor
Ilaria Colombo
Phase
Observational
Overall status
Completed
Start date
February 25, 2021
Completion date
March 21, 2023
Enrollment
177 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, covid19